In the published article, there was an error in affiliation 2 and affiliation 4. Instead of affiliation 2 Shanghai Tongji Hospital, Tongji University School of Medicine, Shanghai, China, it should be Department of Urology, Tongji Hospital, School of Medicine, Tongji University, Shanghai, China. Instead of affiliation 4 Department of Immunology, Medical College, Nantong University, Shanghai, China, it should be Department of Immunology, Medical College, Nantong University, Nantong, China.
Furthermore, we exchanged the order of Affiliations 1 and 2. Therefore, the new Affiliation 1 is 1 Department of Urology, Tongji Hospital, School of Medicine, Tongji University, Shanghai, China and the new Affiliation 2 is 2 School of Medicine, Tongji University, Shanghai, China.
The authors apologize for this error and state that this does not change the scientific conclusions of the article in any way. The original article has been updated.
Summary
Keywords
CDC6, prognosis, clear cell renal cell carcinoma, survival, pathway
Citation
Yao Y, Wang Y, Wu D and Hu B (2021) Corrigendum: Increased CDC6 Expression Associates With Poor Prognosis in Patients With Clear Cell Renal Cell Carcinoma. Front. Oncol. 11:731942. doi: 10.3389/fonc.2021.731942
Received
28 June 2021
Accepted
28 June 2021
Published
21 July 2021
Approved by
Frontiers Editorial Office, Frontiers Media SA, Switzerland
Volume
11 - 2021
Updates
Copyright
© 2021 Yao, Wang, Wu and Hu.
This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
*Correspondence: Denglong Wu, wudenglong2009@tongji.edu.cn; Baoying Hu, huby86@ntu.edu.cn
†These authors have contributed equally to this work
This article was submitted to Genitourinary Oncology, a section of the journal Frontiers in Oncology
Disclaimer
All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.